Is meta-analysis the optimal method to decide the duration of antiplatelet therapy in diabetic patients treated with drug‑eluting stenting?

Pol Arch Intern Med. 2021 Sep 30;131(9):776-778. doi: 10.20452/pamw.16080. Epub 2021 Sep 30.

Authors

Udaya S Tantry¹, Paul A Gurbel

Affiliation

¹ Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, Maryland, United States

PMID: 34590448
DOI: 10.20452/pamw.16080

No abstract available

Publication types

Comment

MeSH terms

Aspirin
Diabetes Mellitus* / drug therapy
Humans
Meta-Analysis as Topic
Pharmaceutical Preparations*
Platelet Aggregation Inhibitors / therapeutic use
Stents
Treatment Outcome

Substances

Pharmaceutical Preparations
Platelet Aggregation Inhibitors
Aspirin